Increasingly, Ozempic is being bought without a doctor’s prescription by people who simply want to lose weight.

The companies that manufacture Ozempic and Mounjaro are set to launch a new weight loss drug that doesn't involve needles.

A new pill, Orforglipron, is set to revolutionize weight loss and diabetes treatment. This daily pill, developed by Eli Lilly ...

This article was reviewed by Mike Bohl, MD. Weight has always been an issue for me. For a long time, I yo-yo-dieted my way through life. But after two kids and the start of perimenopause, the weight ...

Eli Lilly’s new oral GLP-1 drug, orforglipron, is shaping up to be a major development in obesity treatment, showing nearly ...

A drug that can be taken orally could soon rival the likes of Ozempic for treating type 2 diabetes and obesity, according to a new study. Although its efficacy hasn't yet been tested in humans, the ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. The U.S. Food and Drug Administration said ...

As Ozempic and other drugs used for weight loss continue to soar in popularity, the U.S. Food and Drug Administration (FDA) has issued a new warning for consumers. On Thursday, the FDA announced it ...

Weight loss drugs like Wegovy and Ozempic have helped millions in their weight loss (and diabetes) journeys. Now, Novo Nordisk—the creator of Wegovy—has published results of a once-daily oral ...

A new oral GLP-1 receptor agonist, orforglipron, is revolutionizing weight management by offering a needle-free alternative ...